medigraphic.com
ISSN 1870-199X (Print)
Órgano oficial de la Facultad de Odontología, UNAM

2010, Number 3

<< Back Next >>

Rev Odont Mex 2010; 14 (3)

Bilateral maxillary sinus lift using bone grafts and platelet-rich plasma, with the simultaneous and late placement of endosteal implants: Case report

Neria MR, Flores SI

Language: Spanish
References: 63
Page: 185-192
PDF size: 406.71 Kb.


ABSTRACT

The maxillary sinus lift with bone grafts is the most predictable procedure to increase the vertical dimension of an atrophic superior alveolar ridge. With the addition of a platelet concentrate as a growth factor’s source, the tissue regeneration rate and the survival rate of endosteal implants can be increased. A clinical report is presented in which the vertical dimension of the posterior superior alveolar ridge was increased through a maxillary sinus lift procedure using a combination of autogenous and allogenic bone grafts with platelet-rich plasma (PRP) and 2 endosteal implants were placed on the right side simultaneously to the regenerative surgery. In a second procedure, 5 months later, 2 implants were placed on the left side. The 4 implants were uncovered 10 months from the onset of the treatment, 1 month later a 3 unit fixed prosthesis was placed on each side. Throughout a 28 month follow up of the implant-supported fixed prosthesis, the success of the sinus lift procedure and of the endosteal implants, based on clinical osseointegration and radiographic criteria, could be established. The PRP obtained with the 3i PCCS protocol conferred advantages: enough PRP volume, a better manipulation of the graft, and a clean and controlled procedure.


REFERENCES

  1. Linkow LI. Maxillary implants: A dynamic approach to oral implantology. North Haven, Conn, Glarus Publishing. 1977.

  2. Tatum OH. Maxillary and sinus implant reconstruction. Dent Clin North Am 1986; 30: 227-229.

  3. Boyne PJ, James RA. Grafting of the maxillary sinus floor with autogenous marrow and bone. J Oral Surg 1980; 38: 613-616.

  4. Misch CE. Maxillary sinus augmentations for endosteal implants: organized alternative treatment plans. Int J Oral Implantol 1987; 4: 49-58.

  5. Misch CE. Treatment planning for the edentulous posterior maxila. In: Misch CE. Dental implant prosthetics U.S. Elsevier Mosby E; 2005: 265-280.

  6. Woo I, Le BT. Maxillary sinus floor elevation: Review of anatomy and two techniques. Implant Dent 2004; 13: 28-32.

  7. Garg AK. Augmentation grafting of the maxillary sinus for placement of dental implants: anatomy, physiology and procedures. Implant Dent 1999; 8: 36-46.

  8. Del Fabro M, Testori T, Francetti L, Weinstein R. Systematic review of survival rates for implants placed in the grafted maxillary sinus. Int J Periodontics Restorative Dent 2004; 24: 565-577.

  9. Chiapasco M, Zaniboni M, Boisco M. Augmentation procedures for the rehabilitation of deficient edentulous ridges with oral implants. Clin Oral Impl Res 2006; 17(Suppl 2): 136-159.

  10. Stein JI, Greenber AM. Maxillary sinus grafting and osseointegration surgery. In: Davies JE. Bone Engineering. Canada em squared incorporated 2000: 174-197.

  11. Zijderveld SA, Zerbo IR, van den Bergh JP, Schulten EA, ten Bruggenkate CM. Maxillary sinus floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous bone grafts. Int J Oral Maxillofac Implants 2005; 20: 432-40.

  12. Cordaro L. Bilateral simultaneous augmentation of the maxillary sinus floor with particulated mandible. Report of a technique and preliminary results. Clin Oral Implants Res 2003; 14: 201-06.

  13. McCarthy C, Patel RR, Wragg PF, Brook IM. Sinus augmentation bone grafts for the provision of dental implants: report of clinical outcome. Int J Oral Maxillofac Implants 2003; 18: 377-382.

  14. Hallman M, Sennerby L, Lundgren S. A clinical histologic evaluation of implant integration in the posterior maxilla after sinus floor augmentation with autogenous bone, bovine hydroxyapatite, or a 20:80 mixture. Int J Oral Maxillofac Implants 2002; 17: 635-643.

  15. Tadjoedin ES, De Lange GL, Holzmann PJ, Kuiper EH, Burger EH. Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range. Clin Oral Impl Res 2000; 11: 334-344.

  16. Cordiolli G, Mazzocco C, Schepers E, Brugnolo E, Majzoub Z. Maxillary sinus floor augmentation using bioactive glass granules and autogenous bone with simultaneous implant placement. Clinical and histological findings. Clin Oral Impl Res 2001; 12: 270-278.

  17. Tawil G, Mawla M. Sinus floor elevation using a bovine bone mineral (Bio-Oss) with or without the concomitant use of a bilayered collagen barrier (Bio-Guide): a clinical report of immediate and delayed implant placement. Int J Oral Maxillofac Implants 2001; 16: 713-721.

  18. Landi L, Pretel RW Jr, Hakimi NM, Setayesh R. Maxillary sinus floor elevation using a combination of DFDBA and bovine-derived porous hydroxyapatite: a preliminary histologic and histomorphometric report. Int J Periodontics Restorative Dent 2000; 20: 574-583.

  19. Karabuda C, Ozdemir O, Tosun T, Anil A, Olgac V. Histological and clinical evaluation of 3 different grafting materials for sinus lifting procedure based on 8 cases. J Periodontol 2001; 72: 1436-1442.

  20. Andreana S, Cornelini R, Edsberg LE, Natiella JR. Maxillary sinus elevation for implant placement using calcium sulfate with and without DFDBA: six cases. Implant Dent 2004; 13: 270-277.

  21. Hanisch O, Lozada JL, Holmes RE, Calhoun CJ; Kan JYK, Spiekermann H. Maxillary sinus augmentation prior to placement of endosseous Implants: a histomorphometric analysis. Int J Oral Maxillofac Implant 1999; 14: 329-336.

  22. Scher EL, Day RB, Speight PM. New bone formation after a sinus lift procedure using DFDBA and tricalcium phosphate. Implant Dent 1999; 8: 49-53.

  23. Wheeler SL, Holmes RE, Calhoun CJ. Six-year clinical and histologic study of sinus-lift grafts. Int J Oral Maxillofac Implants 1996; 11: 26-34.

  24. Tong DC, Rioux K, Drangsholt M, Beirne OR. A review of survival rates for implants placed in grafted maxillary sinuses using meta-analysis. Int J Oral Maxillofac Implants 1998; 13: 175-182.

  25. Valentini P, Abensur D, Densari D, Graziani JN, Hämmerle CHF. Histological evaluation of Bio-Oss in a 2-stage sinus floor elevation and implantation procedure: a human case report. Clin Oral Impl Res 1998; 9: 59-64.

  26. Olson JW, Dent CD, Morris HF, Ochi S. Long-term assessment (5 to 71 months) of endosseous dental implants placed in the augmented maxillary sinus. Ann Periodontol 2000; 5: 152-156.

  27. Klongnoi B, Rupprecht S, Kessler P, Thorwarth M, Wiltfang J, Schlegel KA. Influence of platelet-rich plasma on a bioglass and autogenous bone in sinus augmentation: an explorative study. Clin Oral Impl Res 2006; 17: 312-320.

  28. Mazor Z, Peleg M, Garg AK, Luboshitz J. Platelet-rich plasma for bone graft enhancement in sinus floor augmentation with simultaneous implant placement: patient series study. Implant Dent 2004; 13: 65-72.

  29. Hallman M, Cederlund A, Lindskog S, Lundgren S, Sennerby L. A clinical histologic study of bovine hydroxyapatite in combination with autogenous bone and fibrin glue for maxillary sinus floor augmentation. Clin Oral Impl Res 2001; 12: 135-143.

  30. Hallman M, Hedin M, Sennerby L, Lundfren S. A prospective 1-year clinical and radiographic study of implants placed after maxillary sinus floor augmentation with bovine hydroxyapatite and autogenous bone. J Oral Maxillofac Surg 2002; 60: 277-284.

  31. Rodriguez A, Anastassov GE; Lee H, Buchbinder D, Wettan H. Maxillary sinus augmentation with deproteinated bovine bone and platelet rich plasma with simultaneous insertion of endosseous implants. J Oral Maxillofac Surg 2003; 61: 157-163.

  32. Kassolis JD, Rosen PS, Reynolds MA. Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with FDBA: case series. J Periodontol 2000; 71: 1654-1661.

  33. Philippart P, Brasseur M, Hoyaux D, Pochet R. Human recombinant tissue factor, platelet-rich plasma, and tetracycline induce a high-quality human bone graft: a 5 year survey. Int J Oral Maxillofac Implants 2003; 18: 411-416.

  34. Kassolis JD, Reynolds MA. Evaluation of the adjunctive benefits of platelet-rich plasma in subantral sinus augmentation. J Craniofac Surg 2005; 16: 280-287.

  35. Danesh-Meyer MJ, Filstein MR, Shanaman R. Histological evaluation of sinus augmentation using platelet rich plasma (PRP): a case series. J Int Acad Periodontol 2001; 3: 48-56.

  36. Yildirim M, Spiekermann H, Biesterfeld S, Edelhoff D. Maxillary sinus augmentation using xenogenic bone substitute material Bio-Oss in combination with venous blood. A histologic and histomorphometric study in humans. Clin Oral Impl Res 2000; 11: 217-229.

  37. Mannai C. Early implant loading in severely resorbed maxilla using xenograft, autograft, and platelet-rich plasma in 97 patients. J Oral Maxillofac Surg 2006; 64: 1420-1426.

  38. Roldan JC, Jepsen S, Schmidt C, Knüppel H, Rueger DC, Açil Y, Terheyden H. Sinus floor augmentation with simultaneous placement of dental implants in the presence of platelet-rich plasma or recombinant human bone morphogenetic protein-7. Clin Oral Impl Res 2004; 15: 716-723.

  39. Froum SJ, Wallace SS, Tarnow DP, Cho S. Effect of platelet-rich plasma on bone growth and osseontegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodontics Restorative Dent 2002; 22: 45-53.

  40. Freymiller EG, Aghaloo TL. Platelet-rich plasma: ready or not? J Oral Maxillofac Sur 2004; 62: 484-488

  41. Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis: effect of oxygen gradients and inspired oxygen concentration. Surgery 1981; 90: 262-270.

  42. Hunt TK The physiology of wound healing. Ann Emerg Med 1988; 17: 1265-1273.

  43. Marx, RE. The biology of platelets and the mechanism of platelet-rich plasma. In. Marx RE, Garg AK. Dental and craniofacial applications of Platelet-Rich Plasma. US Quintessence Publishing 2005: 3–30.

  44. Marx RE. Platelet-rich plasma: Evidence to support its use. J Oral Maxillofac Surg 2004; 62: 489-496.

  45. Marx RE: Platelet-rich plasma (PRP): what is PRP and what is not PRP. Implant Dentistry 2001; 10: 225-228.

  46. Weibrich G, Kleis WKG, Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: Curasan-Type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants 2002; 17: 184-190.

  47. Weibrich G, Kleis WKG. Curasan PRP kit vs PCCS PRP system: collection efficiency and platelet counts of two different methods for the preparation of platelet-rich plasma. Clin Oral Impl Res 2002; 13: 437-443.

  48. Appel TR, Pötzsch B, Müller J, von Lindern JJ, Bergé SJ, Reich RH. Comparison of three different preparation of platelet concentrates for growth factor enrichment. Clin Oral Impl Res 2002; 13: 522-528.

  49. Gonshor A. Technique for producing Platelet-rich plasma and platelet concentrate: background and process. Int J Periodontics Restorative Dent 2002; 22: 547-557.

  50. Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Oral Maxillofac Surg 2000; 58: 297-300.

  51. Dugrillon A, Eicher H, Kern S, Kluter H. Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int J Oral Maxillofac Surg 2002; 31: 615-619.

  52. Tözüm TF, Demiralp B. Platelet-rich plasma: a promising innovation in dentistry. J Can Dent Assoc 2003; 69: 664-664h.

  53. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 638-46.

  54. Peleg M, Mazor Z, Chaushu G, Garg AK. Sinus floor augmentation with simultaneous implant placement in the severely atrophic maxilla. J Periodontol 1998; 69: 1307-1403.

  55. Winter AA, Pollack AS, Odrich RB. Placement of implants in the severely atrophic posterior maxilla using localized management of the sinus floor: a preliminary study. Int J Oral Maxillofac Implants 2002; 7: 687-695.

  56. Wallace SS, Froum SJ. Effect of maxillary sinus augmentation on the survival of endosseous dental implants. A systematic review. Ann Periodont 2003; 8: 328-243.

  57. Garg AK. Current concepts in augmentation grafting of the maxillary sinus for placement of dental implants. Dent Implantol Update 2001; 12: 17-22.

  58. Carlson NE, Roach RB Jr. Platelet-rich plasma. Clinical applications in dentistry. JADA 2002; 133: 1383-1386.

  59. Goto H, Matsuyama T, Miyamoto M, Yonamine Y, Izumi Y. Platelet-rich plasma/osteoblasts complex induces bone formation via osteoblastic differentiations following subcutaneous transplantation. J Periodont Res 2006; 41: 455-462.

  60. Kanno T, Takahashi T, Tsujisawa T, Ariyuoshi W, Nishihara T. Platelet-rich plasma enhances human osteoblast-like cell proliferation and differentiation. J Oral Maxillofac Surg 2005; 63: 362-369.

  61. Raghoebar GM, Schortinghuis J, Liem RSB, Ruben JL, van der Wal JE, Vissink A. Does platelet-rich plasma promote remodeling of autologous bone graft used for augmentation of the maxillary sinus floor? Clin Oral Impl Res 2005; 16: 349-356.

  62. Grageda E, Lozada JL, Boyne PJ, Caplanis N, McMillan PJ. Bone formation in the maxillary sinus by using platelet-rich plasma: an experimental study in sheep. J Oral Implantol 2005; 31: 2-17.

  63. Boyapaty L, Wang HL. The role of platelet-rich plasma in sinus augmentation: a critical review. Implant Dent 2006; 12: 160-170.




2020     |     www.medigraphic.com